Migraine without aura
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Clinical symptoms meeting the diagnostic criteria for migraine without aura; (2) Age between 18-65 years old gender-neutral right-handed; (3) Age of first attack <50 years duration of disease =1 year; (4) The average number of headache attack days per month in the last 3 months was 2-14 days; (5) Study participants with headache attacks of moderate to severe pain (mean VAS score of 4-10); (6) Those who were able to sign the informed consent fill in the headache diary and cooperated in completing the treatment and follow-up visits.
Exclusion criteria
Exclusion criteria: (1) Combined with other primary headache secondary headache and other headache with unknown diagnosis; (2) Those who have a combination of serious primary diseases such as cardiovascular cerebrovascular hepatic renal and hematopoietic systems and other organic lesions; (3) Those with confirmed diagnosis of serious mental disorders such as schizophrenia schizoaffective disorder paranoid psychosis bipolar disorder mental disorder due to epilepsy mental retardation with mental disorder etc; (4) Those with intellectual disabilities who cannot cooperate in completing the questionnaire; (5) Nursing women pregnant or planning to be pregnant; (6) Those who have been taking painkillers for a long time or those who are dependent on painkillers (taking painkillers for more than 15 days in 1 month); (7) Those who have taken medications with clear prophylactic therapeutic effects for migraine within 4 weeks; (8) Those who are allergic to any of the ingredients in the Chinese medicine formula granules used in this study or cannot accept acupuncture; (9) Those who have participated in a clinical study related to migraine preventive treatment within 3 months. (10) Have contraindications to MRI: pacemaker claustrophobia etc; (11) Those with any cranial deformity and intracranial lesions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Migraine Days; | — |
Secondary
| Measure | Time frame |
|---|---|
| Headache Impact Test (HIT-6);Response rate;Migraine-Specific Quality-of-Life Questionnaire(MSQ);Acute analgesic drug treatment frequency;Migraine Duration;Hospital anxiety and depression scale(HADS);visual analogue scale(VAS);Work Productivity and Activity Impairment Questionnaire:Migraine(WPAI);Migraine Attacks; | — |
Countries
China
Contacts
Beijing University of Chinese Medicine Third Affiliated Hospital